Forge Biologics, Case Western Reserve University launch gene therapy workforce development partnership

Forge CEO Timothy J. Miller (center) with CWRU Forge Forward program leadership. (Photo: Business Wire)
With the goal of training and attracting top talent, Columbus-based gene therapy company Forge Biologics has launched the Forge Forward gene therapy workforce development program in partnership with the National Center for Regenerative Medicine (NCRM) at Case Western Reserve University, according to a news release.
Forge Biologics — a gene therapy-focused contract development and manufacturing organization (CDMO) — aims to attract talent with specialized Good Manufacturing Practice (GMP) training to the company in Columbus and beyond as it grows.
"The gene therapy manufacturing boom has created an unmet workforce demand whose training will be foundational for the success of the gene therapy industry," said Timothy J. Miller, CEO, president and co-founder of Forge, in a provided statement. "We are especially excited to be partnering with the NCRM to help expand the talent pool of trained gene therapy manufacturers in the Midwest."

Related Keywords

Case Western Reserve University ,Ohio ,United States ,Columbus ,Cleveland ,Timothyj Miller ,Cheryl Thompson ,Stan Gerson ,Case Western Reserve School Of Medicine ,National Center ,Nasdaq ,Forge Biologics ,Forge Forward ,Regenerative Medicine ,Good Manufacturing Practice ,Abeona Therapeutics ,Case Western Reserve ,வழக்கு மேற்கு இருப்பு பல்கலைக்கழகம் ,ஓஹியோ ,ஒன்றுபட்டது மாநிலங்களில் ,கொலம்பஸ் ,கிளீவ்லேண்ட் ,செரில் தாம்சன் ,ஸ்டான் கெர்சன் ,வழக்கு மேற்கு இருப்பு பள்ளி ஆஃப் மருந்து ,தேசிய மையம் ,நாஸ்டாக் ,மோசடி உயிரியல் ,மோசடி முன்னோக்கி ,மீளுருவாக்கம் மருந்து ,நல்ல உற்பத்தி ப்ர்யாக்டீஸ் ,வழக்கு மேற்கு இருப்பு ,